nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CYP3A4—Pilocarpine—glaucoma	0.0629	0.166	CbGbCtD
Telaprevir—ABCB1—Timolol—glaucoma	0.0603	0.159	CbGbCtD
Telaprevir—ABCB1—Clonidine—glaucoma	0.0513	0.135	CbGbCtD
Telaprevir—CYP3A4—Brinzolamide—glaucoma	0.0494	0.13	CbGbCtD
Telaprevir—CYP3A4—Dorzolamide—glaucoma	0.0477	0.126	CbGbCtD
Telaprevir—CYP3A4—Methazolamide—glaucoma	0.0425	0.112	CbGbCtD
Telaprevir—CYP3A4—Acetazolamide—glaucoma	0.034	0.0897	CbGbCtD
Telaprevir—CYP3A4—Clonidine—glaucoma	0.0307	0.0811	CbGbCtD
Telaprevir—CTSS—Extracellular matrix organization—LOXL1—glaucoma	0.002	0.00733	CbGpPWpGaD
Telaprevir—CTSK—Activation of Matrix Metalloproteinases—MMP9—glaucoma	0.00192	0.00704	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—DHPS—glaucoma	0.00184	0.00673	CbGpPWpGaD
Telaprevir—Oedema peripheral—Bimatoprost—glaucoma	0.00176	0.00506	CcSEcCtD
Telaprevir—CTSS—Extracellular matrix organization—ELN—glaucoma	0.00175	0.0064	CbGpPWpGaD
Telaprevir—Shock—Levobunolol—glaucoma	0.00174	0.00499	CcSEcCtD
Telaprevir—Hepatobiliary disease—Acetazolamide—glaucoma	0.00174	0.00499	CcSEcCtD
Telaprevir—Eye disorder—Apraclonidine—glaucoma	0.00173	0.00495	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.0017	0.00488	CcSEcCtD
Telaprevir—Infestation NOS—Travoprost—glaucoma	0.00168	0.00482	CcSEcCtD
Telaprevir—Infestation—Travoprost—glaucoma	0.00168	0.00482	CcSEcCtD
Telaprevir—CTSK—Collagen degradation—MMP9—glaucoma	0.00167	0.00614	CbGpPWpGaD
Telaprevir—Eye disorder—Bimatoprost—glaucoma	0.00167	0.0048	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Dorzolamide—glaucoma	0.00167	0.00479	CcSEcCtD
Telaprevir—Infestation NOS—Brinzolamide—glaucoma	0.00166	0.00475	CcSEcCtD
Telaprevir—Infestation—Brinzolamide—glaucoma	0.00166	0.00475	CcSEcCtD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP1—glaucoma	0.00163	0.00599	CbGpPWpGaD
Telaprevir—Nervous system disorder—Latanoprost—glaucoma	0.00161	0.00461	CcSEcCtD
Telaprevir—Eczema—Betaxolol—glaucoma	0.0016	0.00459	CcSEcCtD
Telaprevir—Skin disorder—Latanoprost—glaucoma	0.00159	0.00457	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00159	0.00456	CcSEcCtD
Telaprevir—Fatigue—Diclofenamide—glaucoma	0.00159	0.00455	CcSEcCtD
Telaprevir—Dysgeusia—Apraclonidine—glaucoma	0.00157	0.00451	CcSEcCtD
Telaprevir—Hepatobiliary disease—Brinzolamide—glaucoma	0.00157	0.0045	CcSEcCtD
Telaprevir—Erythema multiforme—Acetazolamide—glaucoma	0.00156	0.00448	CcSEcCtD
Telaprevir—Urinary tract disorder—Travoprost—glaucoma	0.00149	0.00427	CcSEcCtD
Telaprevir—Eye disorder—Brimonidine—glaucoma	0.00148	0.00425	CcSEcCtD
Telaprevir—Urethral disorder—Travoprost—glaucoma	0.00148	0.00424	CcSEcCtD
Telaprevir—Urinary tract disorder—Brinzolamide—glaucoma	0.00147	0.00422	CcSEcCtD
Telaprevir—Oedema peripheral—Brinzolamide—glaucoma	0.00147	0.0042	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Methazolamide—glaucoma	0.00146	0.0042	CcSEcCtD
Telaprevir—Fatigue—Methazolamide—glaucoma	0.00146	0.00419	CcSEcCtD
Telaprevir—Urethral disorder—Brinzolamide—glaucoma	0.00146	0.00418	CcSEcCtD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP1—glaucoma	0.00146	0.00534	CbGpPWpGaD
Telaprevir—Asthenia—Metipranolol—glaucoma	0.00145	0.00416	CcSEcCtD
Telaprevir—Syncope—Apraclonidine—glaucoma	0.00144	0.00413	CcSEcCtD
Telaprevir—Erythema multiforme—Dorzolamide—glaucoma	0.00143	0.00411	CcSEcCtD
Telaprevir—Oedema peripheral—Pilocarpine—glaucoma	0.00141	0.00404	CcSEcCtD
Telaprevir—Eye disorder—Travoprost—glaucoma	0.00141	0.00404	CcSEcCtD
Telaprevir—Dysgeusia—Acetazolamide—glaucoma	0.00141	0.00404	CcSEcCtD
Telaprevir—Urticaria—Levobunolol—glaucoma	0.00141	0.00403	CcSEcCtD
Telaprevir—Eye disorder—Brinzolamide—glaucoma	0.00139	0.00399	CcSEcCtD
Telaprevir—ALB—HDL-mediated lipid transport—ABCA1—glaucoma	0.00138	0.00506	CbGpPWpGaD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00136	0.0039	CcSEcCtD
Telaprevir—Dysgeusia—Brimonidine—glaucoma	0.00135	0.00388	CcSEcCtD
Telaprevir—Urticaria—Methazolamide—glaucoma	0.00135	0.00386	CcSEcCtD
Telaprevir—Asthenia—Carteolol—glaucoma	0.00134	0.00385	CcSEcCtD
Telaprevir—Eye disorder—Pilocarpine—glaucoma	0.00134	0.00383	CcSEcCtD
Telaprevir—Dizziness—Metipranolol—glaucoma	0.00134	0.00383	CcSEcCtD
Telaprevir—Asthenia—Diclofenamide—glaucoma	0.00132	0.00379	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00132	0.00378	CcSEcCtD
Telaprevir—Hypokalaemia—Betaxolol—glaucoma	0.00131	0.00375	CcSEcCtD
Telaprevir—Infection—Apraclonidine—glaucoma	0.0013	0.00374	CcSEcCtD
Telaprevir—Pruritus—Diclofenamide—glaucoma	0.0013	0.00374	CcSEcCtD
Telaprevir—Malnutrition—Brinzolamide—glaucoma	0.0013	0.00372	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Betaxolol—glaucoma	0.00129	0.00371	CcSEcCtD
Telaprevir—Dysgeusia—Dorzolamide—glaucoma	0.00129	0.0037	CcSEcCtD
Telaprevir—Nervous system disorder—Apraclonidine—glaucoma	0.00129	0.00369	CcSEcCtD
Telaprevir—Dysgeusia—Travoprost—glaucoma	0.00128	0.00369	CcSEcCtD
Telaprevir—Rash—Metipranolol—glaucoma	0.00127	0.00366	CcSEcCtD
Telaprevir—Skin disorder—Apraclonidine—glaucoma	0.00127	0.00365	CcSEcCtD
Telaprevir—Dermatitis—Metipranolol—glaucoma	0.00127	0.00365	CcSEcCtD
Telaprevir—Asthenia—Levobunolol—glaucoma	0.00127	0.00364	CcSEcCtD
Telaprevir—Dysgeusia—Brinzolamide—glaucoma	0.00127	0.00364	CcSEcCtD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP2—glaucoma	0.00126	0.00464	CbGpPWpGaD
Telaprevir—Infection—Bimatoprost—glaucoma	0.00126	0.00362	CcSEcCtD
Telaprevir—Pruritus—Levobunolol—glaucoma	0.00125	0.00359	CcSEcCtD
Telaprevir—Nervous system disorder—Bimatoprost—glaucoma	0.00125	0.00358	CcSEcCtD
Telaprevir—Dizziness—Carteolol—glaucoma	0.00124	0.00355	CcSEcCtD
Telaprevir—Syncope—Brimonidine—glaucoma	0.00124	0.00355	CcSEcCtD
Telaprevir—Skin disorder—Bimatoprost—glaucoma	0.00124	0.00354	CcSEcCtD
Telaprevir—Diarrhoea—Carbachol—glaucoma	0.00123	0.00353	CcSEcCtD
Telaprevir—Dysgeusia—Pilocarpine—glaucoma	0.00122	0.0035	CcSEcCtD
Telaprevir—Dizziness—Diclofenamide—glaucoma	0.00122	0.00349	CcSEcCtD
Telaprevir—Asthenia—Methazolamide—glaucoma	0.00122	0.00349	CcSEcCtD
Telaprevir—Loss of consciousness—Brimonidine—glaucoma	0.00121	0.00348	CcSEcCtD
Telaprevir—Diarrhoea—Levobunolol—glaucoma	0.00121	0.00347	CcSEcCtD
Telaprevir—Nausea—Metipranolol—glaucoma	0.0012	0.00344	CcSEcCtD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP1—glaucoma	0.0012	0.0044	CbGpPWpGaD
Telaprevir—Dizziness—Carbachol—glaucoma	0.00119	0.00341	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—TGFB2—glaucoma	0.00118	0.00435	CbGpPWpGaD
Telaprevir—Syncope—Dorzolamide—glaucoma	0.00118	0.00339	CcSEcCtD
Telaprevir—Vomiting—Diclofenamide—glaucoma	0.00117	0.00336	CcSEcCtD
Telaprevir—Dizziness—Levobunolol—glaucoma	0.00117	0.00336	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00117	0.00335	CcSEcCtD
Telaprevir—Pruritus—Latanoprost—glaucoma	0.00116	0.00333	CcSEcCtD
Telaprevir—Rash—Diclofenamide—glaucoma	0.00116	0.00333	CcSEcCtD
Telaprevir—Diarrhoea—Methazolamide—glaucoma	0.00116	0.00333	CcSEcCtD
Telaprevir—Loss of consciousness—Dorzolamide—glaucoma	0.00116	0.00332	CcSEcCtD
Telaprevir—Shock—Acetazolamide—glaucoma	0.00115	0.00331	CcSEcCtD
Telaprevir—Thrombocytopenia—Acetazolamide—glaucoma	0.00115	0.00329	CcSEcCtD
Telaprevir—CMA1—Metabolism of proteins—CTSA—glaucoma	0.00115	0.0042	CbGpPWpGaD
Telaprevir—Vomiting—Carbachol—glaucoma	0.00114	0.00328	CcSEcCtD
Telaprevir—Rash—Carbachol—glaucoma	0.00113	0.00325	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00113	0.00325	CcSEcCtD
Telaprevir—Dermatitis—Carbachol—glaucoma	0.00113	0.00325	CcSEcCtD
Telaprevir—Fatigue—Apraclonidine—glaucoma	0.00113	0.00324	CcSEcCtD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP2—glaucoma	0.00113	0.00413	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CTSA—glaucoma	0.00112	0.00412	CbGpPWpGaD
Telaprevir—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00112	0.00411	CbGpPWpGaD
Telaprevir—Infection—Brimonidine—glaucoma	0.00112	0.00321	CcSEcCtD
Telaprevir—Syncope—Pilocarpine—glaucoma	0.00112	0.0032	CcSEcCtD
Telaprevir—Nausea—Carteolol—glaucoma	0.00111	0.00319	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00111	0.00318	CcSEcCtD
Telaprevir—Shock—Brimonidine—glaucoma	0.00111	0.00318	CcSEcCtD
Telaprevir—Infestation—Betaxolol—glaucoma	0.00111	0.00318	CcSEcCtD
Telaprevir—Infestation NOS—Betaxolol—glaucoma	0.00111	0.00318	CcSEcCtD
Telaprevir—Nervous system disorder—Brimonidine—glaucoma	0.0011	0.00317	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Bimatoprost—glaucoma	0.0011	0.00315	CcSEcCtD
Telaprevir—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.0011	0.00402	CbGpPWpGaD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.0011	0.00314	CcSEcCtD
Telaprevir—Loss of consciousness—Pilocarpine—glaucoma	0.00109	0.00314	CcSEcCtD
Telaprevir—Skin disorder—Brimonidine—glaucoma	0.00109	0.00314	CcSEcCtD
Telaprevir—Nausea—Diclofenamide—glaucoma	0.00109	0.00314	CcSEcCtD
Telaprevir—Dizziness—Latanoprost—glaucoma	0.00108	0.00311	CcSEcCtD
Telaprevir—Vomiting—Methazolamide—glaucoma	0.00108	0.00309	CcSEcCtD
Telaprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP9—glaucoma	0.00107	0.00393	CbGpPWpGaD
Telaprevir—Rash—Methazolamide—glaucoma	0.00107	0.00307	CcSEcCtD
Telaprevir—Dermatitis—Methazolamide—glaucoma	0.00107	0.00306	CcSEcCtD
Telaprevir—Eye disorder—Clonidine—glaucoma	0.00107	0.00306	CcSEcCtD
Telaprevir—Nausea—Carbachol—glaucoma	0.00107	0.00306	CcSEcCtD
Telaprevir—Infection—Travoprost—glaucoma	0.00106	0.00305	CcSEcCtD
Telaprevir—Shock—Dorzolamide—glaucoma	0.00106	0.00303	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—TGFB2—glaucoma	0.00106	0.00387	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—ACE2—glaucoma	0.00105	0.00387	CbGpPWpGaD
Telaprevir—Nausea—Levobunolol—glaucoma	0.00105	0.00301	CcSEcCtD
Telaprevir—Infection—Brinzolamide—glaucoma	0.00105	0.00301	CcSEcCtD
Telaprevir—Nervous system disorder—Travoprost—glaucoma	0.00105	0.00301	CcSEcCtD
Telaprevir—Skin disorder—Travoprost—glaucoma	0.00104	0.00298	CcSEcCtD
Telaprevir—Nervous system disorder—Brinzolamide—glaucoma	0.00104	0.00297	CcSEcCtD
Telaprevir—Rash—Latanoprost—glaucoma	0.00103	0.00297	CcSEcCtD
Telaprevir—Dermatitis—Latanoprost—glaucoma	0.00103	0.00296	CcSEcCtD
Telaprevir—Skin disorder—Brinzolamide—glaucoma	0.00103	0.00295	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—BAD—glaucoma	0.00102	0.00374	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00101	0.00291	CcSEcCtD
Telaprevir—Fatigue—Acetazolamide—glaucoma	0.00101	0.0029	CcSEcCtD
Telaprevir—Infection—Pilocarpine—glaucoma	0.00101	0.0029	CcSEcCtD
Telaprevir—Nausea—Methazolamide—glaucoma	0.00101	0.00289	CcSEcCtD
Telaprevir—Shock—Pilocarpine—glaucoma	0.001	0.00287	CcSEcCtD
Telaprevir—Thrombocytopenia—Pilocarpine—glaucoma	0.000995	0.00285	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—TXNIP—glaucoma	0.000984	0.00361	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Brimonidine—glaucoma	0.000972	0.00279	CcSEcCtD
Telaprevir—Fatigue—Brimonidine—glaucoma	0.000971	0.00278	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—TBK1—glaucoma	0.000965	0.00354	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP9—glaucoma	0.000951	0.00349	CbGpPWpGaD
Telaprevir—Asthenia—Apraclonidine—glaucoma	0.000941	0.0027	CcSEcCtD
Telaprevir—Urticaria—Acetazolamide—glaucoma	0.000932	0.00267	CcSEcCtD
Telaprevir—Eye disorder—Betaxolol—glaucoma	0.000929	0.00267	CcSEcCtD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP2—glaucoma	0.000928	0.0034	CbGpPWpGaD
Telaprevir—Pruritus—Apraclonidine—glaucoma	0.000928	0.00266	CcSEcCtD
Telaprevir—Fatigue—Dorzolamide—glaucoma	0.000927	0.00266	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Travoprost—glaucoma	0.000924	0.00265	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—CTSA—glaucoma	0.000924	0.00339	CbGpPWpGaD
Telaprevir—Fatigue—Travoprost—glaucoma	0.000923	0.00265	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000913	0.00262	CcSEcCtD
Telaprevir—Asthenia—Bimatoprost—glaucoma	0.000912	0.00262	CcSEcCtD
Telaprevir—Fatigue—Brinzolamide—glaucoma	0.000912	0.00261	CcSEcCtD
Telaprevir—ALB—HDL-mediated lipid transport—APOE—glaucoma	0.000907	0.00333	CbGpPWpGaD
Telaprevir—Pruritus—Bimatoprost—glaucoma	0.0009	0.00258	CcSEcCtD
Telaprevir—Diarrhoea—Apraclonidine—glaucoma	0.000897	0.00257	CcSEcCtD
Telaprevir—Syncope—Clonidine—glaucoma	0.000892	0.00256	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000877	0.00252	CcSEcCtD
Telaprevir—Loss of consciousness—Clonidine—glaucoma	0.000874	0.00251	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—C1QB—glaucoma	0.000872	0.0032	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—TGFB2—glaucoma	0.00087	0.00319	CbGpPWpGaD
Telaprevir—Dizziness—Apraclonidine—glaucoma	0.000867	0.00249	CcSEcCtD
Telaprevir—Malnutrition—Betaxolol—glaucoma	0.000866	0.00248	CcSEcCtD
Telaprevir—Urticaria—Dorzolamide—glaucoma	0.000854	0.00245	CcSEcCtD
Telaprevir—Dysgeusia—Betaxolol—glaucoma	0.000848	0.00243	CcSEcCtD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP9—glaucoma	0.000847	0.00311	CbGpPWpGaD
Telaprevir—Asthenia—Acetazolamide—glaucoma	0.000842	0.00241	CcSEcCtD
Telaprevir—Dizziness—Bimatoprost—glaucoma	0.000841	0.00241	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000841	0.00241	CcSEcCtD
Telaprevir—Urticaria—Brinzolamide—glaucoma	0.00084	0.00241	CcSEcCtD
Telaprevir—Vomiting—Apraclonidine—glaucoma	0.000834	0.00239	CcSEcCtD
Telaprevir—Dermatitis—Apraclonidine—glaucoma	0.000826	0.00237	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—TXNIP—glaucoma	0.00081	0.00297	CbGpPWpGaD
Telaprevir—Asthenia—Brimonidine—glaucoma	0.000808	0.00232	CcSEcCtD
Telaprevir—Infection—Clonidine—glaucoma	0.000806	0.00231	CcSEcCtD
Telaprevir—Diarrhoea—Acetazolamide—glaucoma	0.000803	0.0023	CcSEcCtD
Telaprevir—Rash—Bimatoprost—glaucoma	0.000802	0.0023	CcSEcCtD
Telaprevir—Dermatitis—Bimatoprost—glaucoma	0.000801	0.0023	CcSEcCtD
Telaprevir—Oedema peripheral—Timolol—glaucoma	0.0008	0.0023	CcSEcCtD
Telaprevir—Anaemia—Betaxolol—glaucoma	0.0008	0.00229	CcSEcCtD
Telaprevir—Shock—Clonidine—glaucoma	0.000798	0.00229	CcSEcCtD
Telaprevir—Pruritus—Brimonidine—glaucoma	0.000797	0.00229	CcSEcCtD
Telaprevir—Nervous system disorder—Clonidine—glaucoma	0.000796	0.00228	CcSEcCtD
Telaprevir—Thrombocytopenia—Clonidine—glaucoma	0.000795	0.00228	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—TBK1—glaucoma	0.000794	0.00291	CbGpPWpGaD
Telaprevir—ALB—Lipoprotein metabolism—ABCA1—glaucoma	0.000792	0.00291	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—LRP12—glaucoma	0.000791	0.0029	CbGpPWpGaD
Telaprevir—Skin disorder—Clonidine—glaucoma	0.000788	0.00226	CcSEcCtD
Telaprevir—Nausea—Apraclonidine—glaucoma	0.000779	0.00223	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—TXN—glaucoma	0.000778	0.00285	CbGpPWpGaD
Telaprevir—Syncope—Betaxolol—glaucoma	0.000776	0.00223	CcSEcCtD
Telaprevir—Dizziness—Acetazolamide—glaucoma	0.000776	0.00223	CcSEcCtD
Telaprevir—Asthenia—Dorzolamide—glaucoma	0.000772	0.00221	CcSEcCtD
Telaprevir—Asthenia—Travoprost—glaucoma	0.000768	0.0022	CcSEcCtD
Telaprevir—Pruritus—Dorzolamide—glaucoma	0.000761	0.00218	CcSEcCtD
Telaprevir—Loss of consciousness—Betaxolol—glaucoma	0.000761	0.00218	CcSEcCtD
Telaprevir—Eye disorder—Timolol—glaucoma	0.000759	0.00218	CcSEcCtD
Telaprevir—Asthenia—Brinzolamide—glaucoma	0.000759	0.00218	CcSEcCtD
Telaprevir—Pruritus—Travoprost—glaucoma	0.000758	0.00217	CcSEcCtD
Telaprevir—Nausea—Bimatoprost—glaucoma	0.000755	0.00217	CcSEcCtD
Telaprevir—Pruritus—Brinzolamide—glaucoma	0.000748	0.00215	CcSEcCtD
Telaprevir—Vomiting—Acetazolamide—glaucoma	0.000746	0.00214	CcSEcCtD
Telaprevir—Dizziness—Brimonidine—glaucoma	0.000745	0.00214	CcSEcCtD
Telaprevir—Diarrhoea—Dorzolamide—glaucoma	0.000736	0.00211	CcSEcCtD
Telaprevir—Diarrhoea—Travoprost—glaucoma	0.000733	0.0021	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000732	0.0021	CcSEcCtD
Telaprevir—CTSS—Collagen formation—MMP9—glaucoma	0.000731	0.00268	CbGpPWpGaD
Telaprevir—Asthenia—Pilocarpine—glaucoma	0.000729	0.00209	CcSEcCtD
Telaprevir—Diarrhoea—Brinzolamide—glaucoma	0.000723	0.00207	CcSEcCtD
Telaprevir—Pruritus—Pilocarpine—glaucoma	0.000719	0.00206	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—C1QB—glaucoma	0.000718	0.00263	CbGpPWpGaD
Telaprevir—Dizziness—Dorzolamide—glaucoma	0.000711	0.00204	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—CDKN1B—glaucoma	0.00071	0.0026	CbGpPWpGaD
Telaprevir—Rash—Brimonidine—glaucoma	0.00071	0.00204	CcSEcCtD
Telaprevir—Dermatitis—Brimonidine—glaucoma	0.000709	0.00203	CcSEcCtD
Telaprevir—Dizziness—Travoprost—glaucoma	0.000708	0.00203	CcSEcCtD
Telaprevir—Malnutrition—Timolol—glaucoma	0.000707	0.00203	CcSEcCtD
Telaprevir—Infection—Betaxolol—glaucoma	0.000702	0.00201	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Clonidine—glaucoma	0.000701	0.00201	CcSEcCtD
Telaprevir—Fatigue—Clonidine—glaucoma	0.0007	0.00201	CcSEcCtD
Telaprevir—Dizziness—Brinzolamide—glaucoma	0.000699	0.00201	CcSEcCtD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP9—glaucoma	0.000698	0.00256	CbGpPWpGaD
Telaprevir—Nausea—Acetazolamide—glaucoma	0.000697	0.002	CcSEcCtD
Telaprevir—Diarrhoea—Pilocarpine—glaucoma	0.000695	0.00199	CcSEcCtD
Telaprevir—Shock—Betaxolol—glaucoma	0.000695	0.00199	CcSEcCtD
Telaprevir—Nervous system disorder—Betaxolol—glaucoma	0.000693	0.00199	CcSEcCtD
Telaprevir—Dysgeusia—Timolol—glaucoma	0.000693	0.00199	CcSEcCtD
Telaprevir—Thrombocytopenia—Betaxolol—glaucoma	0.000692	0.00198	CcSEcCtD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000691	0.00253	CbGpPWpGaD
Telaprevir—Skin disorder—Betaxolol—glaucoma	0.000686	0.00197	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—MMP1—glaucoma	0.000685	0.00251	CbGpPWpGaD
Telaprevir—Vomiting—Dorzolamide—glaucoma	0.000684	0.00196	CcSEcCtD
Telaprevir—CTSK—Immune System—CTSA—glaucoma	0.000681	0.0025	CbGpPWpGaD
Telaprevir—Rash—Dorzolamide—glaucoma	0.000678	0.00194	CcSEcCtD
Telaprevir—Dermatitis—Dorzolamide—glaucoma	0.000677	0.00194	CcSEcCtD
Telaprevir—Rash—Travoprost—glaucoma	0.000675	0.00194	CcSEcCtD
Telaprevir—Dermatitis—Travoprost—glaucoma	0.000675	0.00193	CcSEcCtD
Telaprevir—Vomiting—Brinzolamide—glaucoma	0.000672	0.00193	CcSEcCtD
Telaprevir—Dizziness—Pilocarpine—glaucoma	0.000672	0.00193	CcSEcCtD
Telaprevir—Nausea—Brimonidine—glaucoma	0.000669	0.00192	CcSEcCtD
Telaprevir—Rash—Brinzolamide—glaucoma	0.000667	0.00191	CcSEcCtD
Telaprevir—Dermatitis—Brinzolamide—glaucoma	0.000666	0.00191	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—MMP9—glaucoma	0.000658	0.00241	CbGpPWpGaD
Telaprevir—Vomiting—Pilocarpine—glaucoma	0.000646	0.00185	CcSEcCtD
Telaprevir—Urticaria—Clonidine—glaucoma	0.000645	0.00185	CcSEcCtD
Telaprevir—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000644	0.00236	CbGpPWpGaD
Telaprevir—Rash—Pilocarpine—glaucoma	0.000641	0.00184	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—TXN—glaucoma	0.00064	0.00235	CbGpPWpGaD
Telaprevir—Dermatitis—Pilocarpine—glaucoma	0.00064	0.00184	CcSEcCtD
Telaprevir—Nausea—Dorzolamide—glaucoma	0.000639	0.00183	CcSEcCtD
Telaprevir—Nausea—Travoprost—glaucoma	0.000636	0.00182	CcSEcCtD
Telaprevir—Syncope—Timolol—glaucoma	0.000634	0.00182	CcSEcCtD
Telaprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000628	0.0023	CbGpPWpGaD
Telaprevir—Nausea—Brinzolamide—glaucoma	0.000628	0.0018	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—FN1—glaucoma	0.000625	0.00229	CbGpPWpGaD
Telaprevir—Loss of consciousness—Timolol—glaucoma	0.000622	0.00178	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—MMP1—glaucoma	0.00061	0.00224	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Betaxolol—glaucoma	0.00061	0.00175	CcSEcCtD
Telaprevir—Fatigue—Betaxolol—glaucoma	0.000609	0.00175	CcSEcCtD
Telaprevir—Nausea—Pilocarpine—glaucoma	0.000604	0.00173	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000598	0.00171	CcSEcCtD
Telaprevir—Asthenia—Clonidine—glaucoma	0.000582	0.00167	CcSEcCtD
Telaprevir—Pruritus—Clonidine—glaucoma	0.000574	0.00165	CcSEcCtD
Telaprevir—Infection—Timolol—glaucoma	0.000573	0.00164	CcSEcCtD
Telaprevir—CTSK—Immune System—TXNIP—glaucoma	0.000573	0.0021	CbGpPWpGaD
Telaprevir—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000569	0.00209	CbGpPWpGaD
Telaprevir—Shock—Timolol—glaucoma	0.000568	0.00163	CcSEcCtD
Telaprevir—Nervous system disorder—Timolol—glaucoma	0.000566	0.00162	CcSEcCtD
Telaprevir—CMA1—Metabolism of proteins—PAX6—glaucoma	0.000562	0.00206	CbGpPWpGaD
Telaprevir—CTSK—Immune System—TBK1—glaucoma	0.000562	0.00206	CbGpPWpGaD
Telaprevir—Urticaria—Betaxolol—glaucoma	0.000561	0.00161	CcSEcCtD
Telaprevir—Skin disorder—Timolol—glaucoma	0.000561	0.00161	CcSEcCtD
Telaprevir—CTSS—Immune System—CTSA—glaucoma	0.00056	0.00206	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—FN1—glaucoma	0.000557	0.00204	CbGpPWpGaD
Telaprevir—Diarrhoea—Clonidine—glaucoma	0.000555	0.00159	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—OPN4—glaucoma	0.000548	0.00201	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—TXN—glaucoma	0.000542	0.00199	CbGpPWpGaD
Telaprevir—Dizziness—Clonidine—glaucoma	0.000537	0.00154	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—MMP2—glaucoma	0.00053	0.00194	CbGpPWpGaD
Telaprevir—ALB—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.000527	0.00193	CbGpPWpGaD
Telaprevir—ALB—Lipoprotein metabolism—APOE—glaucoma	0.000521	0.00191	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—ABCA1—glaucoma	0.000518	0.0019	CbGpPWpGaD
Telaprevir—Vomiting—Clonidine—glaucoma	0.000516	0.00148	CcSEcCtD
Telaprevir—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000515	0.00189	CbGpPWpGaD
Telaprevir—Rash—Clonidine—glaucoma	0.000512	0.00147	CcSEcCtD
Telaprevir—Dermatitis—Clonidine—glaucoma	0.000511	0.00147	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—HEYL—glaucoma	0.00051	0.00187	CbGpPWpGaD
Telaprevir—CTSK—Immune System—C1QB—glaucoma	0.000508	0.00186	CbGpPWpGaD
Telaprevir—Asthenia—Betaxolol—glaucoma	0.000507	0.00145	CcSEcCtD
Telaprevir—CTSS—Extracellular matrix organization—MMP1—glaucoma	0.000503	0.00184	CbGpPWpGaD
Telaprevir—Pruritus—Betaxolol—glaucoma	0.0005	0.00143	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Timolol—glaucoma	0.000498	0.00143	CcSEcCtD
Telaprevir—Fatigue—Timolol—glaucoma	0.000498	0.00143	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—PTGFR—glaucoma	0.000494	0.00181	CbGpPWpGaD
Telaprevir—Diarrhoea—Betaxolol—glaucoma	0.000483	0.00139	CcSEcCtD
Telaprevir—Nausea—Clonidine—glaucoma	0.000482	0.00138	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—MMP2—glaucoma	0.000472	0.00173	CbGpPWpGaD
Telaprevir—CTSS—Immune System—TXNIP—glaucoma	0.000472	0.00173	CbGpPWpGaD
Telaprevir—Dizziness—Betaxolol—glaucoma	0.000467	0.00134	CcSEcCtD
Telaprevir—CTSS—Immune System—TBK1—glaucoma	0.000463	0.0017	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—SOD1—glaucoma	0.000462	0.00169	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—FN1—glaucoma	0.000459	0.00168	CbGpPWpGaD
Telaprevir—Urticaria—Timolol—glaucoma	0.000459	0.00132	CcSEcCtD
Telaprevir—CTSK—Immune System—TXN—glaucoma	0.000453	0.00166	CbGpPWpGaD
Telaprevir—Vomiting—Betaxolol—glaucoma	0.000449	0.00129	CcSEcCtD
Telaprevir—Rash—Betaxolol—glaucoma	0.000445	0.00128	CcSEcCtD
Telaprevir—Dermatitis—Betaxolol—glaucoma	0.000445	0.00128	CcSEcCtD
Telaprevir—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000431	0.00158	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—TGFB2—glaucoma	0.000425	0.00156	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—ABCA1—glaucoma	0.000422	0.00155	CbGpPWpGaD
Telaprevir—Nausea—Betaxolol—glaucoma	0.00042	0.0012	CcSEcCtD
Telaprevir—CTSS—Immune System—C1QB—glaucoma	0.000418	0.00153	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000416	0.00153	CbGpPWpGaD
Telaprevir—Asthenia—Timolol—glaucoma	0.000414	0.00119	CcSEcCtD
Telaprevir—Pruritus—Timolol—glaucoma	0.000408	0.00117	CcSEcCtD
Telaprevir—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—glaucoma	0.000406	0.00149	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.000405	0.00149	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—MMP9—glaucoma	0.000398	0.00146	CbGpPWpGaD
Telaprevir—Diarrhoea—Timolol—glaucoma	0.000395	0.00113	CcSEcCtD
Telaprevir—CTSS—Extracellular matrix organization—MMP2—glaucoma	0.000389	0.00143	CbGpPWpGaD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000387	0.00142	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RPTOR—glaucoma	0.000386	0.00142	CbGpPWpGaD
Telaprevir—Dizziness—Timolol—glaucoma	0.000382	0.00109	CcSEcCtD
Telaprevir—ALB—Folate Metabolism—SOD1—glaucoma	0.000376	0.00138	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NCK2—glaucoma	0.000374	0.00137	CbGpPWpGaD
Telaprevir—CTSS—Immune System—TXN—glaucoma	0.000373	0.00137	CbGpPWpGaD
Telaprevir—Vomiting—Timolol—glaucoma	0.000367	0.00105	CcSEcCtD
Telaprevir—ALB—Vitamin B12 Metabolism—MTHFR—glaucoma	0.000366	0.00134	CbGpPWpGaD
Telaprevir—Rash—Timolol—glaucoma	0.000364	0.00104	CcSEcCtD
Telaprevir—Dermatitis—Timolol—glaucoma	0.000364	0.00104	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—MMP9—glaucoma	0.000355	0.0013	CbGpPWpGaD
Telaprevir—ALB—Lipid and lipoprotein metabolism—APOE—glaucoma	0.000346	0.00127	CbGpPWpGaD
Telaprevir—ALB—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.000343	0.00126	CbGpPWpGaD
Telaprevir—Nausea—Timolol—glaucoma	0.000343	0.000983	CcSEcCtD
Telaprevir—ALB—Vitamin B12 Metabolism—APOE—glaucoma	0.000341	0.00125	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—C3—glaucoma	0.000339	0.00124	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—ABCA1—glaucoma	0.000335	0.00123	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—C3—glaucoma	0.000326	0.0012	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—BCL2L1—glaucoma	0.000325	0.00119	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—SOD1—glaucoma	0.000322	0.00118	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—MMP1—glaucoma	0.00032	0.00117	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HDAC9—glaucoma	0.000318	0.00117	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—PEX19—glaucoma	0.000313	0.00115	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000307	0.00113	CbGpPWpGaD
Telaprevir—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000304	0.00111	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000299	0.0011	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—SOD1—glaucoma	0.000299	0.00109	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—MTHFR—glaucoma	0.000298	0.00109	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—BAD—glaucoma	0.000294	0.00108	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—MMP9—glaucoma	0.000292	0.00107	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—BAD—glaucoma	0.000283	0.00104	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—C3—glaucoma	0.000279	0.00102	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000278	0.00102	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000274	0.00101	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—C3—glaucoma	0.000268	0.000984	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—BCL2L1—glaucoma	0.000268	0.000981	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000257	0.000943	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SMO—glaucoma	0.000249	0.000913	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—MMP2—glaucoma	0.000248	0.000908	CbGpPWpGaD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000246	0.000901	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—BAD—glaucoma	0.000242	0.000889	CbGpPWpGaD
Telaprevir—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000242	0.000889	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	0.000237	0.000868	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—BAD—glaucoma	0.000233	0.000854	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—FAS—glaucoma	0.000229	0.000841	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NTRK2—glaucoma	0.000228	0.000835	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—C3—glaucoma	0.000226	0.000829	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL1A—glaucoma	0.000225	0.000825	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—FN1—glaucoma	0.000224	0.000822	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.000214	0.000783	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000211	0.000775	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CDKN1B—glaucoma	0.000205	0.000752	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000203	0.000745	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.0002	0.000734	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000199	0.00073	CbGpPWpGaD
Telaprevir—CTSK—Immune System—C3—glaucoma	0.000198	0.000725	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CDKN1B—glaucoma	0.000197	0.000722	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NGFR—glaucoma	0.000195	0.000716	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000194	0.00071	CbGpPWpGaD
Telaprevir—CTSK—Immune System—BCL2L1—glaucoma	0.000189	0.000694	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000189	0.000692	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NTRK1—glaucoma	0.000186	0.000681	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL1A—glaucoma	0.000185	0.000679	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000185	0.000679	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000183	0.000671	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CA5A—glaucoma	0.000172	0.000632	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NARFL—glaucoma	0.000172	0.000632	CbGpPWpGaD
Telaprevir—CTSK—Immune System—BAD—glaucoma	0.000171	0.000629	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN2B—glaucoma	0.000171	0.000627	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CDKN1B—glaucoma	0.000169	0.000619	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EDN1—glaucoma	0.000164	0.000602	CbGpPWpGaD
Telaprevir—CTSS—Immune System—C3—glaucoma	0.000163	0.000597	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CDKN1B—glaucoma	0.000162	0.000595	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—TNF—glaucoma	0.000158	0.000578	CbGpPWpGaD
Telaprevir—CTSS—Immune System—BCL2L1—glaucoma	0.000156	0.000571	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NARFL—glaucoma	0.000151	0.000554	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CA5A—glaucoma	0.000151	0.000554	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	0.000151	0.000554	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NGF—glaucoma	0.000151	0.000553	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000144	0.00053	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—C3—glaucoma	0.000143	0.000526	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000143	0.000524	CbGpPWpGaD
Telaprevir—CTSS—Immune System—BAD—glaucoma	0.000141	0.000518	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000141	0.000517	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—APOE—glaucoma	0.000133	0.00049	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000133	0.000488	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000133	0.000487	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CAV1—glaucoma	0.000132	0.000485	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000132	0.000485	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000131	0.000481	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—glaucoma	0.000128	0.000471	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TNF—glaucoma	0.000128	0.000471	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FN1—glaucoma	0.000126	0.000462	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—BAD—glaucoma	0.000124	0.000456	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000124	0.000453	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.000122	0.000448	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDKN1B—glaucoma	0.000119	0.000438	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—glaucoma	0.000114	0.000417	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000113	0.000415	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—glaucoma	0.000113	0.000415	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP1B1—glaucoma	0.000106	0.000388	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	0.000104	0.000383	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000103	0.000379	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—TNF—glaucoma	0.000102	0.000374	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NOS3—glaucoma	0.0001	0.000367	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	9.95e-05	0.000365	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDKN1B—glaucoma	9.83e-05	0.000361	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TNF—glaucoma	9.73e-05	0.000357	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB2—glaucoma	9.72e-05	0.000357	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	9.68e-05	0.000355	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CA5A—glaucoma	9.3e-05	0.000341	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NARFL—glaucoma	9.3e-05	0.000341	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.04e-05	0.000332	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN1B—glaucoma	8.66e-05	0.000318	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTM1—glaucoma	8.46e-05	0.00031	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CA1—glaucoma	8.42e-05	0.000309	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	8.34e-05	0.000306	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CTSA—glaucoma	8.15e-05	0.000299	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MMP9—glaucoma	8.02e-05	0.000294	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CA2—glaucoma	7.7e-05	0.000282	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.52e-05	0.000276	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.52e-05	0.000276	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CA1—glaucoma	7.38e-05	0.000271	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SOD1—glaucoma	7.37e-05	0.00027	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—glaucoma	7.2e-05	0.000264	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CTSA—glaucoma	7.14e-05	0.000262	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	7.12e-05	0.000261	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CA2—glaucoma	6.75e-05	0.000247	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.74e-05	0.000247	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	5.69e-05	0.000209	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MMP1—glaucoma	5.62e-05	0.000206	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.61e-05	0.000206	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—glaucoma	5.44e-05	0.0002	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TXN—glaucoma	5.42e-05	0.000199	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CAV1—glaucoma	5.39e-05	0.000198	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—FN1—glaucoma	5.13e-05	0.000188	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.95e-05	0.000182	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.9e-05	0.00018	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.8e-05	0.000176	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TXN—glaucoma	4.75e-05	0.000174	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CA1—glaucoma	4.54e-05	0.000167	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CTSA—glaucoma	4.4e-05	0.000161	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.24e-05	0.000155	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTT1—glaucoma	4.21e-05	0.000154	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CA2—glaucoma	4.16e-05	0.000152	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS3—glaucoma	4.07e-05	0.000149	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTT1—glaucoma	3.69e-05	0.000135	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.39e-05	0.000124	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1B1—glaucoma	3.35e-05	0.000123	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCA1—glaucoma	3.35e-05	0.000123	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ABCA1—glaucoma	2.94e-05	0.000108	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1B1—glaucoma	2.94e-05	0.000108	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—glaucoma	2.93e-05	0.000108	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TXN—glaucoma	2.93e-05	0.000107	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTM1—glaucoma	2.68e-05	9.83e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTHFR—glaucoma	2.37e-05	8.68e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTM1—glaucoma	2.35e-05	8.61e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTT1—glaucoma	2.27e-05	8.33e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—glaucoma	2.22e-05	8.13e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—APOE—glaucoma	2.2e-05	8.08e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CAV1—glaucoma	2.18e-05	8.01e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTHFR—glaucoma	2.07e-05	7.61e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—APOE—glaucoma	1.93e-05	7.08e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CAV1—glaucoma	1.91e-05	7.02e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1B1—glaucoma	1.81e-05	6.63e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCA1—glaucoma	1.81e-05	6.63e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NOS3—glaucoma	1.65e-05	6.06e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—glaucoma	1.51e-05	5.54e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NOS3—glaucoma	1.45e-05	5.31e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTM1—glaucoma	1.45e-05	5.3e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—glaucoma	1.32e-05	4.85e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTHFR—glaucoma	1.28e-05	4.69e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—APOE—glaucoma	1.19e-05	4.36e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CAV1—glaucoma	1.18e-05	4.32e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NOS3—glaucoma	8.91e-06	3.27e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—glaucoma	8.15e-06	2.99e-05	CbGpPWpGaD
